RecruitingNot Applicable

Amino Acid Transporter System PET/CT Imaging in AATS-Related Diseases

China500 participantsStarted 2013-08-29

Plain-language summary

To evaluate the potential usefulness of 11C/18F-MET/FET positron emission tomography/ computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in various amino acid transporter system (AATS)-related disease patients.

Who can participate

Age range18 Years – 90 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. adult patients (aged 18 years or order);
✓. patients with suspected or newly diagnosed or previously treated malignant tumors (supporting evidence may include MRI, CT, tumor markers and pathology report);
✓. patients who had scheduled AATS PET/CT scan;
✓. patients who were able to provide informed consent (signed by participant, parent or legal representative) and assent according to the guidelines of the Clinical Research Ethics Committee.

Exclusion criteria

✕. patients with non-malignant lesions;
✕. patients with pregnancy;
✕. the inability or unwillingness of the research participant, parent or legal representative to provide written informed consent.

What they're measuring

Standardized uptake value (SUV)

Timeframe: 30 days

Trial details

NCT IDNCT07379463

SponsorTianjin Medical University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2033-08-29

Contact for this trial

Haonan Yu, MD

+8613821000597 dreamadam@126.com

View on ClinicalTrials.gov More Amino-Acid Transport Disorder trials